CAM
ATRS

Cortina Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Cortina Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$6.82M Buy
2,072,605
+1,037,675
+100% +$3M 0.42% 90
2019
Q1 		$3.14M Buy
+1,034,930
New +$3.35M 0.2% 165

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

Cortina Asset Management's ATRS Position: Q2 2019 in Review

Cortina Asset Management increased its Antares Pharma, Inc. (ATRS) stake by 100% in Q2 2019, buying an estimated $3M and bringing the position to 2,072,605 shares worth $6.82M. The position accounts for 0.42% of the portfolio, ranked #90.

Cortina Asset Management first reported a position in ATRS in Q1 2019 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold ATRS as of Q2 2019.

  • Cortina Asset Management held 2,072,605 shares of Antares Pharma, Inc. worth $6.82M as of Q2 2019.
  • Cortina Asset Management bought 1,037,675 Antares Pharma, Inc. shares in Q2 2019, an estimated $3M.
  • Antares Pharma, Inc. made up 0.42% of Cortina Asset Management's portfolio in Q2 2019, its #90 holding.
  • Cortina Asset Management first reported a position in Antares Pharma, Inc. in Q1 2019 and has held it in 2 quarters since.
  • 127 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2019.

Based on Cortina Asset Management's 13F filing for Q2 2019, filed 2 Jul 2019.